Neogen (NEOG) CEO Nassif Mikheal Buys $6K of Stock

Nassif Mikheal, the CEO of Neogen Corp, bought 505 shares of the company on October 9, 2026, at a price of $11.95 each. This purchase totaled approximately $6,034.75. This move continues a trend of insider buying, as Mikheal has been active in the stock this year.

Inside Nassif Mikheal's Trade

Mikheal's recent buy adds to his previous purchases earlier in 2026. He acquired shares on multiple occasions, including 370 shares on August 4 at $11.81 each, and smaller buys in January and February. This ongoing investment could signal his confidence in Neogen's future performance.

Other Institutional Activity in Neogen Corp

Blackrock Inc. increased its stake by 809,025 shares, bringing its total to 33,431,015 shares valued at about $394.8 million. Neuberger Berman Group, LLC also raised its holdings significantly, adding 8,819,102 shares for a total of 16,570,795 shares worth approximately $195.7 million. Vanguard Portfolio Management LLC and Dimensional Fund Advisors LP made smaller adjustments, with Vanguard adding 206,597 shares and Dimensional increasing by 695,881 shares, bringing their totals to 13,038,732 shares and 9,828,174 shares, respectively.

Neogen Corp Stock Down 4.7%

As of October 16, 2026, Neogen's stock was recently trading around $11.70, which is below its 50-day moving average of $12.15 and 18% lower than its 52-week high of $14.26. However, it is above its 52-week low of $5.37, indicating some resilience in the stock despite recent challenges.

Recent Earnings

Neogen reported trailing twelve-month revenue of $884 million. The company has faced challenges, with a net margin of -6.3% and a return on equity of -2.7%. The next earnings report is expected on January 7, 2027.

Insider Buying and Selling at Neogen Corp

Earlier this year, Mikheal Nassif bought a total of 579 shares across several transactions, with the most recent purchase of 370 shares on August 4 at $11.81 each. His earlier buys included 137 shares at $9.33 on January 16 and 49 shares on February 2, reflecting a consistent strategy of increasing his stake in the company.

Analysts Set New Price Targets

Analysts have been optimistic about Neogen Corp, with Piper Sandler upgrading its rating to Overweight on August 26, 2026, and setting a price target of $14.00. Guggenheim also maintains a Buy rating with a similar target of $14.00, reflecting a consensus among analysts.

About Neogen Corp

Neogen Corporation develops and markets products for food and animal safety, serving both U.S. and international markets. Its focus on safety solutions in the healthcare sector makes it a key player in ensuring food quality and animal health.

Bottom Line

Investors should watch for Neogen's upcoming earnings report on January 7, 2027, and further insider trading activity, as Mikheal Nassif's recent purchases may indicate his confidence in the company's direction.